false
zh-CN,zh-TW,en,fr,de,ja,ko,pt,es,th,vi
Catalog
2023 ACMG Annual Clinical Genetics Meeting Digital ...
Evaluating the utility of gene expression profile ...
Evaluating the utility of gene expression profile testing in pediatric melanoma: a Case Series
Back to course
Pdf Summary
This document is a case series that evaluates the utility of gene expression profile (GEP) testing in pediatric melanoma. The authors report on three cases of pediatric and adolescent melanoma and their outcomes. Only two of the patients underwent GEP testing, resulting in Class 2A and 2B classifications. Patient A, classified as Class 2B, underwent extensive treatment including surgery, radiation, and immunotherapy but remained disease-free. Patient B, classified as 2A, was observed closely and also remained disease-free. Patient C, who declined GEP testing and opted for observation, developed metastases. <br /><br />The case series highlights the potential influence of GEP testing on patient therapy and outcomes but acknowledges the need for additional studies to determine its clinical value. The abstract provides more details about each patient's diagnosis, treatment, and outcomes. Patient A, a 13-year-old male, was diagnosed with melanoma at Stage IIIc and received various treatments without subsequent metastases. Patient B, a 20-year-old female, was diagnosed at Stage II and was closely observed without metastases. Patient C, who did not undergo GEP testing and opted for observation, developed metastases.<br /><br />The document concludes that GEP testing appears to inform clinicians and patients about their risk of metastasis and recurrence in five years. However, more research is needed to assess the utility of GEP testing in pediatric patients and to determine its use in screening for melanoma in children with risk factors.<br /><br />Overall, this study suggests that GEP testing may provide valuable information for risk assessment and treatment decisions in pediatric melanoma cases, but further research is necessary to fully understand its potential benefits.
Asset Subtitle
Presenting Author - Acacia Bowden, BA; Co-Author - Jeanette Zambito, MD; Co-Author - Jinia El-Feghaly, MD; Co-Author - Jeffrey Andolina, MS, MD;
Meta Tag
Counseling
Genetic Testing
Co-Author
Jeanette Zambito, MD
Co-Author
Jinia El-Feghaly, MD
Co-Author
Jeffrey Andolina, MS, MD
Presenting Author
Acacia Bowden, BA
Keywords
gene expression profile testing
pediatric melanoma
case series
utility
outcomes
GEP testing classifications
treatment options
metastases
risk assessment
pediatric patients
© 2025 American College of Medical Genetics and Genomics. All rights reserved.
×